이상반응 보고

VAERS ID 993884
성별 알 수 없음
나이
주 코드 FR
제약회사 PFIZER\BIONTECH
로트 번호
예방접종 횟수
접종일 2021-01-14
발병일 2021-01-14
상태 후유증
증상
  • 떨림(Tremor)
  • SARS-CoV-2 테스트(SARS-CoV-2 test)
  • 근육 약화(Muscular weakness)

이환 중 질병

지병

Medical History/Concurrent Conditions: Anxiety; Bladder pacemaker insertion; Contraception; Depression; Migraine; Slipped disc

기타 의료

SERTRALINE; ZELLETA

이전 예방접종

알레르기

임상 검사

Test Date: 20210114; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative

증상 상세

Shaking; Weakness of limbs; This is a spontaneous report received by Pfizer from the Regulatory Agency.
The regulatory authority report number is GB-MHRA-APPCOVID-20210115002838, Safety Report Unique Identifier: GB-MHRA-ADR 24597970.
A contactable healthcare professional reported that a 24-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation.
Medical history included anxiety, contraception, bladder pacemaker, depression, migraines, and 2 slipped discs.
Concomitant medications included sertraline from 15Sep2020 for anxiety and desogestrel (ZELLETA) from 11Jan2021 for contraception.
The patient has not had symptoms associated with COVID-19.
The patient is not enrolled in clinical trial.
The patient experienced shaking and weakness of limbs on 14Jan2021.
The reported events were considered serious due to disability.
The patient underwent lab tests and procedures which included COVID-19 virus test: "No - Negative".
The outcome of event shaking was recovering; and outcome of event weakness of limbs was not recovered.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.